U.S. Quetiapine Intermediate Chemicals Market Size & Outlook
Related Markets
U.S. quetiapine intermediate chemicals market highlights
- The U.S. quetiapine intermediate chemicals market generated a revenue of USD 4,693.5 million in 2024 and is expected to reach USD 6,017.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.2% from 2025 to 2030.
- In terms of segment, pharmaceuticals was the largest revenue generating end use in 2024.
- Pharmaceuticals is the most lucrative end use segment registering the fastest growth during the forecast period.
Quetiapine intermediate chemicals market data book summary
| Market revenue in 2024 | USD 4,693.5 million |
| Market revenue in 2030 | USD 6,017.5 million |
| Growth rate | 4.2% (CAGR from 2025 to 2030) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Pharmaceuticals |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceuticals |
Other key industry trends
- In terms of revenue, U.S. accounted for 9.5% of the global quetiapine intermediate chemicals market in 2024.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. quetiapine intermediate chemicals market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 2,292.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Quetiapine Intermediate Chemicals Market Scope
Quetiapine Intermediate Chemicals Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Allchem Lifescience | View profile | 101-250 | Vadodara, Gujarat, India, Asia | https://www.allchemlifescience.com |
| A.R. Life Sciences | View profile | 101-250 | Hyderabad, Andhra Pradesh, India, Asia | https://www.arlifesciences.com |
| AMI Organics | View profile | 251-500 | Sachin, Gujarat, India, Asia | http://amiorganics.com |
| Iol Chemicals & Pharmaceutical | View profile | 1001-5000 | Ludhiana, Punjab, India, Asia | https://www.iolcp.com/ |
| Luye Pharma Group Ltd | View profile | 5270 | Hongqiao Road 1438, 22/F, Gubei International Fortune Center II, Changning District, Shanghai, China, People's Republic of, 264003 | https://www.luye.cn |
| Aarti Pharmalabs Limited | View profile | - | https://www.aartipharmalabs.com/ | |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
U.S. quetiapine intermediate chemicals market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to quetiapine intermediate chemicals market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 89.07% in 2024. Horizon Databook has segmented the U.S. quetiapine intermediate chemicals market based on pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of mental health disorders in the US, including schizophrenia and bipolar disorder, sustains a consistent demand for quetiapine and its intermediates.
Ongoing pharmaceutical research and development, focusing on improved formulations and delivery systems, requires these chemicals. The continued emphasis on generic drug production, aiming to reduce healthcare costs, further contributes to the increasing demand for quetiapine intermediates in the US.
Reasons to subscribe to U.S. quetiapine intermediate chemicals market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. quetiapine intermediate chemicals market databook
-
Our clientele includes a mix of quetiapine intermediate chemicals market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. quetiapine intermediate chemicals market , including forecasts for subscribers. This country databook contains high-level insights into U.S. quetiapine intermediate chemicals market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. quetiapine intermediate chemicals market size, by end use, 2018-2030 (US$M)
U.S. Quetiapine Intermediate Chemicals Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
